Dual Execs at CIRM Severely Weaken Oversight, CIRM Directors Told
California's top fiscal officer today called on directors of the state's $3 billion stem cell agency to overhaul the role of its chairman, declaring that oversight of the enterprise is "severely compromised" when the chair is part of management.
In a letter to the 29 members of the CIRM board of directors, State Controller John Chiang said,
"It is diffic…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.